Author

F. Kabinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Approach:biophysical modeling· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

A. Kumar· 1 shared A. N. Koehler· 1 shared A. Richters· 1 shared A.-S. Koglin· 1 shared C. A. Whittaker· 1 shared C. Dienemann· 1 shared C. Höbartner· 1 shared C. J. Ott· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Kumar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeted Degradation of CDK9 Potently Disrupts the MYC Transcriptional Network

M. A. Toure, K. Motoyama, Y. Xiang, J. Urgiles, F. Kabinger, A.-S. Koglin, R. S. Iyer, K. Gagnon, A. Kumar, S. Ojeda, D. A. Harrison, M. G. Rees, J. A. Roth, C. J. Ott, R. Schiavoni, , A. N. Koehler

This study shows that CDK9 degradation with KI-CDK9d-32 is more effective than inhibition in disrupting MYC transcriptional networks and causes MYC downregulation and nucleolar destabilization.

bioRxiv · May 14, 2024 · PreprintCancer Biology

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

F. Kabinger, C. Stiller, J. Schmitzova, C. Dienemann, H. S. Hillen, C. Höbartner, P. Cramer

This paper identifies the molecular mechanism by which molnupiravir induces SARS-CoV-2 RNA mutations through its interaction with the viral RNA-dependent RNA polymerase.

bioRxiv · May 11, 2021Biochemistry